AI for Clinics and Private Practice
Most clinics should buy rather than build, and we will say so early. This page is about the cases where that is not true, and about how to choose between products without being sold to.
AI work has a fixed engineering cost that does not shrink with the size of the practice. That single fact determines almost everything on this page, and it is why our advice to most clinics is to choose a product carefully rather than commission a build.
AI for clinics and private practice covers ambient consultation documentation, appointment scheduling and no-show reduction, patient communication and triage-adjacent routing, and billing and coding support — most of which is available as a product and only occasionally worth building.
The volume test, applied honestly
Before anything else, work out how often the process you want to automate actually happens. A custom model has a fixed cost to build, validate and maintain. Divide that by the number of times per year the process runs and compare it with what the process currently costs. For most single-site practices the arithmetic settles the question immediately and the answer is to buy.
| Situation | Build or buy | Why |
|---|---|---|
| Consultation documentation | Buy | Mature product category with real competition. Nothing to gain from a custom build. |
| Appointment reminders and no-show prediction | Buy, usually | Your practice management vendor probably has it. Worth building only at multi-site scale with unusual patterns. |
| Patient communication and routing | Buy | Products exist and carry the compliance burden. Building means you carry it. |
| A workflow genuinely unique to your speciality | Possibly build | This is the real case for custom work, and it is rarer than it sounds. |
| Group or multi-site with a shared, high-volume process | Consider building | Volume changes the arithmetic. This is where we can genuinely help. |
We will tell you to buy, and it costs us the engagement
This is not modesty. A clinic that commissions a custom build for something available as a subscription ends up with a system nobody maintains, no upgrade path, and a supplier dependency it did not need. We would rather spend an unpaid hour helping you evaluate three products — see AI vendor selection — than take a build fee for something that should not be built.
How to evaluate a clinical AI product without being sold to
Ask what happens to your patient data
Specifically: is it used to train the vendor's models, where is it processed, who can access it, what happens when you cancel, and can you get it back in a usable form. Vague answers on any of these are the answer. Get it in the contract rather than in the sales deck.
Ask for performance on practices like yours
Aggregate accuracy across all customers tells you nothing about your speciality, your accents, your consultation length or your documentation style. Ask for figures from practices resembling yours, and run a trial on your own consultations before committing.
Work out the exception rate, not the accuracy rate
A documentation tool that is ninety-five per cent accurate still means every twentieth note needs real correction, and the clinician has to read all twenty to find it. Time saved depends on how quickly errors are spotted, which depends on how the output is presented. Trial it and time it.
Check the exit before you check the price
What you can export, in what format, and how long it takes. A tool holding two years of your notes in a proprietary format is a commercial position, not a product feature.
Where the regulatory line sits for a small practice
Administrative AI — scheduling, reminders, documentation drafting a clinician reviews and signs — sits outside medical device regulation and outside the EU AI Act's high-risk categories. The moment a tool triages, advises or influences a clinical decision without a clinician in the loop, the picture changes entirely, and the boundary is easier to cross than most vendors admit.
- A symptom checker that tells a patient to see a doctor today is doing triage, and triage is a regulated activity in most jurisdictions.
- A chatbot answering medication questions is giving advice, whatever the disclaimer says.
- A documentation tool a clinician reviews and signs is a typing aid, and the clinician remains responsible for the content.
- New York requires disclosure when a patient is interacting with AI rather than a person, and other states are following.
- Mental-health-adjacent chatbots are being legislated separately — Tennessee's restrictions took effect in July 2026, with a further ten states having introduced bills.
How an engagement runs
Most engagements here are short, advisory, and end with a recommendation to buy something.
Volume and cost arithmetic
How often the process runs, what it costs now, and what a custom build would have to save to justify itself.
Market scan
What products exist, what they actually do, what they cost at your scale and what their data terms say.
Structured trial
Two or three candidates run on your own consultations, timed, with the exception rate measured rather than estimated.
Recommendation
Which product, or that none of them fit and here is what a build would cost and save.
Scoped delivery
Only where the volume test passes. Smallest useful thing first, with a real measurement of whether it helped.
What you receive
A decision you can defend, usually about which product to license.
Volume and cost analysis
The arithmetic that decides build versus buy, with your numbers rather than industry averages.
Product comparison
What each candidate does, its data terms, its exit terms and its real cost at your scale.
Trial results
Measured on your consultations — time saved, exception rate, what clinicians actually said.
Data and compliance review
Where patient data goes, whether that is acceptable, and what to require in the contract.
Implementation plan
How to roll it out without losing a fortnight to a bad first week.
Written recommendation
Including, frequently, that you should not spend money on this at all.
Is this the right starting point?
Worth being direct. There are situations in clinics and private practice where custom AI work is the wrong spend, and those are listed rather than buried.
Worth doing if
- You are a group or multi-site practice with a genuinely high-volume shared process.
- Your speciality has a workflow no product serves, and you have volume behind it.
- You are being quoted a large sum for something that sounds simple and want an independent read.
- You have evaluated products, none fit, and you want to know what a build would really cost.
- You need help choosing between products without a vendor doing the choosing.
Do something else if
- A single-site practice wanting documentation help — a product will serve you better and cost less.
- The process happens a few times a week. The arithmetic will not work and we will show you why.
- You want a patient-facing advice tool. That is a regulated activity, not a quick build.
- The real problem is the practice management system. Replacing it beats layering AI on it.
Frequently asked questions
Marked up with FAQPage schema so these answers can surface directly in search results and inside AI assistant responses.
Is custom AI worth it for a single clinic?
Almost never, and we will say so in the first conversation rather than after a discovery phase. The engineering cost is fixed regardless of your size, so the question is whether the process happens often enough to repay it. For most single-site practices it does not, and a well-chosen product is genuinely the better answer — we are happy to help you choose one.
Are ambient documentation tools worth the money?
For most clinicians yes, with a caveat about what they buy you. Measured effects are real but modest, and they show up as less after-hours documentation rather than as more patients seen. If the business case you are building assumes extra clinic capacity, it will not survive contact with reality. If it is about clinicians finishing at a reasonable hour, it holds up well.
What are the rules on AI in patient communication?
Administrative communication — reminders, results notification, scheduling — is straightforward. Anything approaching triage or advice is a regulated activity in most jurisdictions regardless of the disclaimer attached. New York already requires disclosure when a patient is interacting with AI rather than a person, several states are following, and Tennessee has legislated specifically on mental-health chatbots. Assume the strictest rule that applies to any state you operate in.
Our practice management vendor is selling us an AI module. Should we buy it?
Possibly, and the questions are the same as for any product: what does it do on practices like yours, what is the exception rate on your own data, what happens to your data, and what does exit look like. Bundling is convenient and integration matters, but it is not evidence of quality. Trial it before the contract, not after.
Can you just tell us whether we are being overcharged?
Yes, and that is a legitimate short engagement. We will look at what is being proposed, what it would actually take to build, and what it should cost. We charge for the assessment and not for whatever happens next, precisely so the answer is not for sale — the same principle as AI due diligence.
Related verticals
Organisations in clinics and private practice usually share data, buyers or regulators with these. All fourteen are listed on the Healthcare & Life Sciences page.
AI for Telemedicine and Virtual Care
Intake, routing and documentation for virtual care — with the line between routing and regulated triage drawn precisely.
Read more →AI for Mental Health Services
Administrative and measurement support for mental health services — with therapeutic interaction firmly out of scope.
Read more →AI for Dental Practices
Radiograph analysis, recall and claims — where DSO scale changes the build-versus-buy answer.
Read more →Tell us what the problem looks like.
Thirty minutes, no charge, no deck. We will tell you whether this is an AI problem, a data problem, or a process problem — and we will say when the honest answer is to buy something rather than build it.